Cancer Control Journal Vol 3, No 4, CME Pretest

This Journal provides 4 hours of Category I Continuing Medical Education

Complimentary CME Credits

Physicans can earn up to 4 credit hours of Category I for the Physican's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

• Know the regulation of apoptosis relating to tumor resistance
• Understand the effects of chemotherapy and radiation on a variety of tumors
• Know the toxicities of combined radiation and chemotherapy for intrathoracic tumors
• Be aware of the role of chemotherapy in trating metastatic adenoid cystic carcinoma
• Understand the management of low-risk febrile neutropenia
• Be familiar with clinical practice guidelines for managing gynecologic cancer

This program was planned in accordance with ACCME Essentials.
Release Date: August 15, 1996 Expiration Date: August 15, 1997

Pretest

1. What is the principal mechanism of action of paclitaxel?

a. topoisomerase I inhibitor

b. single- and double-strand DNA breaks

c. interference with mitotic spindle function

d. intercalator of both DNA and RNA

2. In management of patients with localized rectal cancer with chemoradiation, the optimal method of administering fluorouracil is:

a. bolus injections

b. continuous intravenous infusion

c. intra-arterial (hepatic) infusion

d. oral administration

3. Radiation-induced pneumonitis may respond to treatment with:

a. high-dose ascorbic acid

b. NSAIDs

c. corticosteroids

d. sucralfate